Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
<em><strong>Objective(s):</strong> </em>The primary cytotoxic effects of anticancer drugs like idarubicin, a chemotherapeutic agent, are not limited to neoplastic cells; they also produce similar effects in normal cells. In this study, we hypothesized that the combination of...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2019-10-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_13602_ad87db01b810c1dadeca260d87a4a00e.pdf |